Agios’ first-in-class PK activator Pyrukynd scores FDA approval to treat rare blood disorder esagonowsky Thu, 02/17/2022 – 16:45
Category: Uncategorized
New research discovered a unique class of medications that act as blood thinners by inhibiting an enzyme in […]
Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterial infection that has become resistant to most of the antibiotics used […]
Scientists from Rochester Institute of Technology and Cornell University have teamed up to explore cartilage tissue’s unique properties […]
The name of a member of the DRAFFT2 Collaborators (Charalambos P Charalambous) was incorrect in this article by […]
An important opportunity to alleviate the workforce crisis in the NHS and social care has been missed by […]
bmj;376/feb17_9/o418/FAF1faChristine White was born in West Kilbride in western Scotland. The daughter of a school teacher and a […]
Eliquis partners BMS, Pfizer double down on heart health with renewed ‘No Time to Wait’ campaign badams Thu, […]
Women’s telehealth startup Alloy turns up the heat on men to bring attention to menopause symptoms nmissakian Thu, […]
